In March 2022, the Russians bought more than 134 billion rubles of medicine. That’s 2.6 times more than in March 2021, Writer TASS refers to the Center for Advanced Technologies Development (CRPT, operator of the Chestny Znak digital marking system).
CRPT Deputy General Manager Revaz Yusupov stated that the physical sales volume also grew by 98.15 percent.
“If in March 2021 more than 215 million packages of drugs were sold, in March of this year – already more than 427 million packages,” said Yusupov.
Yusupov does not expect a shortage of drugs.
“We have the necessary drugs, a significant stock of drugs has been built up based on the labeling data,” he said.
The top 3 drugs in demand were xylometazoline (18 million units sold, up 34% year-on-year), bisoprolol (8.8 million units, 3.1-fold increase) and ibuprofen (8.7 million packages, +83%). . .
According to socialbites.ca’s report, the CRPT said that there was a sufficient supply of ibuprofen-based drugs in Russia before and there was no risk of shortages as the business was transferred to the British Reckitt Benckiser company in Russia.